Clinical Trials for Late Stage Lung Cancer
Lung Cancer
Clinical Trials for Late Stage Lung Cancer
Clinical trials help researchers identify new and potentially more effective cancer therapies. In general, doctors will test such new drugs in individuals with late stage cancers who have not had success with other more conventional therapies. That said, the earlier that people with lung cancer receive therapies – including immunotherapy or targeted therapies – the greater the benefit.
Lung cancer can make you feel very sick, which presents challenges for participating in clinical trials as they often require more doctor visits, more imaging and more blood tests. The National Cancer Institute lists all cancer trials on its website, and your doctor can determine whether you are a suitable candidate.
Learn more about SurvivorNet's rigorous medical review process.
Clinical trials help researchers identify new and potentially more effective cancer therapies. In general, doctors will test such new drugs in individuals with late stage cancers who have not had success with other more conventional therapies. That said, the earlier that people with lung cancer receive therapies – including immunotherapy or targeted therapies – the greater the benefit.
Lung cancer can make you feel very sick, which presents challenges for participating in clinical trials as they often require more doctor visits, more imaging and more blood tests. The National Cancer Institute lists all cancer trials on its website, and your doctor can determine whether you are a suitable candidate.
Learn more about SurvivorNet's rigorous medical review process.
Later Stage Treatment: New Approaches
Employing the immune system is now a viable treatment option for many more people with advanced-stage lung cancer.
Later Stage Treatment: Immunotherapy
Employing the immune system is now a viable treatment option for many more people with advanced-stage lung cancer.